Drugs Made In America Acquisition DMAAR Revenue Breakdown

NASDAQ DMAAR
$0.13 +0.01 (+8.33%)
At close: Sep 17, 2026 · 4:00 PM EDT
No revenue breakdown for DMAAR Drugs Made In America Acquisition Corp. does not report revenue split by segment, product or geography.